None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Sexually active women of age (30-59) years 2. Have not been previously diagnosed with cervical cancer 3. Are not pregnant 4. Provide informed consent
Exclusion criteria
Exclusion criteria: 1. Have had a total hysterectomy 2. Have a history of cervical cancer 3. Are pregnant or have been pregnant in the last month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.The subjects participation in screening and treatment, rates of positivity on screening, positive predictive values, CIN grades, and cancer-detection rates will be calculated as proportions. 2.Potential risk factors for high-risk human papillomavirus (HR-HPV) infection and cofactors for cervical dysplasia will be evaluated. 3.Most common genotypes among high risk HPV DNA positives will be known. Genotypes will be correlated with grades of cervical dysplasiaTimepoint: Yearly upto 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Potential risk factors for high-risk human papillomavirus (HR-HPV) infection and cofactors for cervical dysplasia will be evaluated. 2.Most common genotypes among high risk HPV DNA positives will be known. Genotypes will be correlated with grades of cervical dysplasiaTimepoint: Yearly and at the end of 3 years | — |
Countries
India
Contacts
ICMR National Institute for Research in Reproductive Health